ReVision Optics Inc. in Lake Forest raised $32 million in an equity round led by Johnson & Johnson Development Corp. in New Brunswick, N.J.
ReVision will use the money to push commercialization of an implant to improve near vision in patients with presbyopia, which received FDA approval in June.
The company’s Raindrop Near Vision Inlay is placed on the cornea and works by reshaping the anterior curvature of the cornea.
The J&J investment unit is the venture capital arm of the international medical products company.
The parent company agreed in September to buy Abbott Medical Optics in Santa Ana for $4.3 billion from Abbott Laboratories Inc. in Illinois, in a deal expected to close early next year.
Other participants in the recent round include current investors Canaan Partners and InterWest Partners LLC, both in Menlo Park; Domain Associates LLC in San Diego and Princeton, N.J.; and ProQuest Investments in Princeton, N.J. and Naples, Fla.
